{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:22:50Z","timestamp":1782343370189,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["321190602"],"award-info":[{"award-number":["321190602"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jointm.2022.05.006","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T02:04:59Z","timestamp":1656986699000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical efficacy and safety of linezolid in intensive care unit patients"],"prefix":"10.1016","volume":"3","author":[{"given":"Aijia","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenggong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5715-3900","authenticated-orcid":false,"given":"Yan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jointm.2022.05.006_bib0001","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CCM.0000000000004783","article-title":"Nosocomial infection","volume":"49","author":"Kollef","year":"2021","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2007.01835.x","article-title":"Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units","volume":"14","author":"Blot","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0003","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13054-020-03091-2","article-title":"Update of the treatment of nosocomial pneumonia in the ICU","volume":"24","author":"Zaragoza","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0004","first-page":"372","article-title":"Reducing catheter-associated urinary tract infections in the ICU","volume":"23","author":"Sampathkumar","year":"2017","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","article-title":"Necrotizing skin and soft-tissue infections in the intensive care unit","volume":"26","author":"Peetermans","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jointm.2022.05.006_bib0006","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2334-14-92","article-title":"Treatment of Gram-positive infections in critically ill patients","volume":"14","author":"Vazquez-Guillamet","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"Suppl_1","key":"10.1016\/j.jointm.2022.05.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw828","article-title":"Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doernberg","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.006_bib0008","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.006_bib0009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jac\/dkw450","article-title":"Linezolid: a promising option in the treatment of Gram-positives","volume":"72","author":"Zahedi Bialvaei","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jointm.2022.05.006_bib0010","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.006_bib0011","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/CCM.0b013e3181eb3b96","article-title":"Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis","volume":"38","author":"Kalil","year":"2010","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.006_bib0012","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/jac\/dkv411","article-title":"A randomized, double-blind, Phase 2 study to evaluate subjective and objective outcomes in patients with acute bacterial skin and skin structure infections treated with delafloxacin, linezolid or vancomycin","volume":"71","author":"Kingsley","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0013","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3111\/13696998.2015.1088448","article-title":"Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a phase 4 clinical trial study","volume":"19","author":"Wan","year":"2016","journal-title":"J Med Econ"},{"key":"10.1016\/j.jointm.2022.05.006_bib0014","article-title":"Vancomycin-resistant Enterococcus faecium bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome","author":"Rosa","year":"2014","journal-title":"Biomed Res Int 2014"},{"issue":"7","key":"10.1016\/j.jointm.2022.05.006_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/bdd.1910","article-title":"Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients","volume":"35","author":"El-Assal","year":"2014","journal-title":"Biopharm Drug Dispos"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.006_bib0016","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jac\/dks467","article-title":"Daptomycin for the treatment of infective endocarditis: results from a European registry","volume":"68","author":"Dohmen","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.006_bib0017","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12325-015-0231-3","article-title":"Daptomycin for Gram-positive infections in patients with neutropenia: clinical experience from a European Outcomes Registry","volume":"32","author":"Keil","year":"2015","journal-title":"Adv Ther"},{"issue":"Suppl_2","key":"10.1016\/j.jointm.2022.05.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy657","article-title":"Current status and trends of antibacterial resistance in China","volume":"67","author":"Hu","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.006_bib0019","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/fmb.14.146","article-title":"Fighting antibiotic resistance in the intensive care unit using antibiotics","volume":"10","author":"Plantinga","year":"2015","journal-title":"Future Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.jointm.2022.05.006_bib0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0213-005X(17)30028-9","article-title":"Actualizaci\u00f3n en la resistencia antibi\u00f3tica en Gram positivos [Update on antibiotic resistance in Gram-positive bacteria]","volume":"35","author":"Lozano","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"12","key":"10.1016\/j.jointm.2022.05.006_bib0021","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/molecules25122888","article-title":"Resistance of Gram-positive bacteria to current antibacterial agents and overcoming approaches","volume":"25","author":"Karaman","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/38.5.865","article-title":"Penetration of vancomycin into human lung tissue","volume":"38","author":"Cruciani","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0023","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1378\/chest.10-1556","article-title":"Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials","volume":"139","author":"Walkey","year":"2011","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0024","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00228-014-1775-x","article-title":"Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis","volume":"71","author":"Wang","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003912","article-title":"Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis","volume":"3","author":"Kalil","year":"2013","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw504","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jointm.2022.05.006_bib0027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgar.2020.12.009","article-title":"Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus","volume":"24","author":"Kato","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0028","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13054-019-2523-5","article-title":"Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients","volume":"23","author":"Fern\u00e1ndez-Barat","year":"2019","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.006_bib0029","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1086\/497143","article-title":"Practice guidelines for the diagnosis and management of skin and soft-tissue infections","volume":"41","author":"Stevens","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0030","article-title":"Linezolid versus vancomycin for skin and soft tissue infections","author":"Yue","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0031","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jval.2010.12.006","article-title":"Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis","volume":"14","author":"Bounthavong","year":"2011","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.006_bib0032","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.006_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jointm.2022.05.006_bib0034","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.006_bib0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10096-019-03803-9","article-title":"Molecular characteristics and predictors of mortality among Gram-positive bacteria isolated from bloodstream infections in critically ill patients during a 5-year period (2012-2016)","volume":"39","author":"Papadimitriou-Olivgeris","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.006_bib0036","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.006_bib0037","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"16","key":"10.1016\/j.jointm.2022.05.006_bib0038","article-title":"Linezolid and reversible myelosuppression","volume":"286","author":"Abena","year":"1973","journal-title":"JAMA 2001"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.006_bib0039","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1128\/AAC.47.6.1824-1831.2003","article-title":"Worldwide assessment of Linezolid's clinical safety and tolerability: comparator-controlled phase III studies","volume":"47","author":"Rubinstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.006_bib0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcp.14965","article-title":"Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: a systematic review and meta-analysis","volume":"8w8","author":"Shi","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.006_bib0041","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00431-014-2307-5","article-title":"Efficacy and safety of linezolid for the treatment of infections in children: a meta-analysis","volume":"173","author":"Ioannidou","year":"2014","journal-title":"Eur J Pediatr"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:02:38Z","timestamp":1763024558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X22000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2667100X22000524"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2022.05.006","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy and safety of linezolid in intensive care unit patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2022.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}